저침습수술 시장 예측(-2030년) : 제품 유형, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Minimally Invasive Surgery Market is accounted for $81.9 billion in 2024 and is expected to reach $170.5 billion by 2030 growing at a CAGR of 13.0% during the forecast period. Minimally Invasive Surgery involves performing surgical procedures through small incisions, utilizing advanced technologies like laparoscopes and robotic systems, to reduce trauma to the body. This approach leads to shorter recovery times, less pain, reduced scarring, and a lower risk of complications compared to traditional open surgery. The growth is driven by technological advancements, increasing patient preference for less invasive procedures, and the expanding applications of MIS techniques across various medical fields, resulting in their widespread adoption and development.

According to the European Society of Cardiology (ESC), minimally invasive cardiac surgeries, such as transcatheter aortic valve replacement (TAVR), have become increasingly popular due to their lower risk and shorter recovery times compared to traditional open-heart surgeries.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The rising incidence of chronic diseases such as cardiovascular disorders, cancer, and diabetes is driving the demand for minimally invasive surgeries. These procedures offer reduced recovery times, lower risk of infection, and less postoperative pain, making them a preferred choice for both patients and healthcare providers. As the global population ages and the prevalence of chronic conditions increases, the demand for minimally invasive surgical techniques is expected to grow significantly.

Restraint:

High cost of equipment and procedures

Advanced technologies such as robotic-assisted surgery systems and high-definition imaging devices are expensive, making them less accessible to smaller healthcare facilities and patients in low-income regions. These costs can limit the adoption of minimally invasive techniques, particularly in developing countries where healthcare budgets are constrained.

Opportunity:

Increasing investment in healthcare

Growing investments in healthcare infrastructure and technological advancements present significant opportunities for the minimally invasive surgery market. Governments and private entities are increasingly funding healthcare projects, including the development of advanced surgical tools and training programs for medical professionals. These investments are expected to enhance the accessibility and efficiency of minimally invasive procedures, driving market growth.

Threat:

Risk of complications

Despite the benefits, minimally invasive surgeries carry risks such as complications from anesthesia, infections, and accidental damage to surrounding tissues. These potential complications can deter patients and healthcare providers from opting for minimally invasive techniques. Additionally, the need for specialized training and expertise to perform these procedures can limit their widespread adoption, posing a threat to market growth.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the minimally invasive surgery market. Elective surgeries were postponed or canceled to prioritize Covid-19 patients, leading to a temporary decline in demand. However, the pandemic also highlighted the importance of minimally invasive techniques in reducing hospital stays and minimizing patient exposure to infections, which is expected to drive long-term growth in the market.

The laparoscopic instruments segment is expected to be the largest during the forecast period

The laparoscopic instruments segment is expected to register largest market share during the forecast period due to their widespread use in various surgical procedures, including gastrointestinal, gynecological, and urological surgeries. These instruments offer precision, reduced recovery times, and minimal scarring, making them highly popular among surgeons and patients. The continuous advancements in laparoscopic technology and the increasing number of laparoscopic procedures are driving the growth of this segment.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and convenient alternatives to traditional hospital-based surgeries, with shorter procedure times and faster patient recovery. The growing preference for outpatient surgeries, coupled with advancements in minimally invasive techniques, is driving the rapid growth of ASCs. Additionally, the increasing number of ASCs and favorable reimbursement policies are contributing to the segment's expansion.

Region with largest share:

North America is positioned to dominate the minimally invasive surgery market due to its advanced healthcare infrastructure, high adoption of innovative surgical technologies, and the presence of key market players. The region's well-established healthcare system and significant investments in research and development contribute to its leading market share. Additionally, the high prevalence of chronic diseases and the increasing demand for minimally invasive procedures further drive market growth in North America.

Region with highest CAGR:

The Asia Pacific region anticipates rapid growth in the minimally invasive surgery market, driven by the increasing healthcare expenditure, rising awareness about minimally invasive techniques, and improving healthcare infrastructure. Countries like China, India, and Japan are witnessing significant investments in healthcare and technological advancements, which are expected to boost the adoption of minimally invasive surgeries. The growing medical tourism industry and the increasing prevalence of chronic diseases also contribute to the region's high CAGR.

Key players in the market

Some of the key players in Minimally Invasive Surgery Market include Medtronic plc, Johnson & Johnson (Ethicon), Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Inc., Abbott Laboratories, B. Braun Melsungen AG, ConMed Corporation, Karl Storz SE & Co. KG, Cook Medical, Applied Medical Resources Corporation, Richard Wolf GmbH, FUJIFILM Holdings Corporation, HOYA Corporation, Teleflex Incorporated, Arthrex, Inc. and NuVasive, Inc.

Key Developments:

In March 2023, Medtronic received FDA clearance for its Steerable Flex Robotic Clip Applier used with the Hugo system for minimally invasive gynecologic procedures.

In January 2023, Ethicon launched the ECHELON+ Stapler for minimally invasive colorectal, gastric, and thoracic surgeries.

In January 2023, Boston Scientific received FDA approval for its EXALT Model D Single-Use Duodenoscope for minimally invasive endoscopic procedures.

Product Types Covered:

• Laparoscopic Instruments
• Guiding Devices
• Inflation Systems
• Imaging & Visualization Systems
• Electrosurgical Devices
• Endoscopy Devices
• Medical Robotics

Applications Covered:

• Cardio-Thoracic Surgery
• Vascular Surgery
• Neurological Surgery
• ENT & Respiratory Surgery
• Cosmetic Surgery
• Gastrointestinal & Abdominal Surgery
• Gynecological Surgery
• Urological Surgery
• Orthopedic Surgery
• Oncology Surgery
• Dental Surgery
• Other Applications

End Users Covered:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Minimally Invasive Surgery Market, By Product Type

• 5.1 Introduction
• 5.2 Laparoscopic Instruments
  • 5.2.1 Tubular Retractors
  • 5.2.2 Dilators
  • 5.2.3 Suturing Instruments
    • 5.2.3.1 Probes
    • 5.2.3.2 Laser Fiber Devices
• 5.3 Guiding Devices
  • 5.3.1 Guiding Catheters
  • 5.3.2 Guidewires
• 5.4 Inflation Systems
  • 5.4.1 Balloon Catheters
  • 5.4.2 Balloon Inflation Systems
• 5.5 Imaging & Visualization Systems
  • 5.5.1 Laparoscopes
  • 5.5.2 Trocars and Cannulas
  • 5.5.3 Visualization Systems
• 5.6 Electrosurgical Devices
  • 5.6.1 Electrosurgical Generators & Accessories
  • 5.6.2 Electrocautery Devices
• 5.7 Endoscopy Devices
  • 5.7.1 Rigid Endoscopes
  • 5.7.2 Flexible Endoscopes
  • 5.7.3 Diagnostic Endoscopes
• 5.8 Medical Robotics
  • 5.8.1 Robotic Surgical Systems
  • 5.8.2 Robotic Instruments
  • 5.8.3 Robotic Software & Services

6 Global Minimally Invasive Surgery Market, By Application

• 6.1 Introduction
• 6.2 Cardio-Thoracic Surgery
• 6.3 Vascular Surgery
• 6.4 Neurological Surgery
• 6.5 ENT & Respiratory Surgery
• 6.6 Cosmetic Surgery
• 6.7 Gastrointestinal & Abdominal Surgery
  • 6.7.1 Laparoscopic Cholecystectomy
  • 6.7.2 Laparoscopic Appendectomy
  • 6.7.3 Other Gastrointestinal & Abdominal Surgeries
• 6.8 Gynecological Surgery
• 6.9 Urological Surgery
• 6.10 Orthopedic Surgery
  • 6.10.1 Arthroscopy
  • 6.10.2 Joint Replacement
  • 6.10.3 Other Orthopedic Surgeries
• 6.11 Oncology Surgery
• 6.12 Dental Surgery
• 6.13 Other Applications

7 Global Minimally Invasive Surgery Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Specialty Clinics
• 7.5 Research Institutes
• 7.6 Other End Users

8 Global Minimally Invasive Surgery Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Medtronic plc
• 10.2 Johnson & Johnson (Ethicon)
• 10.3 Stryker Corporation
• 10.4 Boston Scientific Corporation
• 10.5 Olympus Corporation
• 10.6 Smith & Nephew plc
• 10.7 Zimmer Biomet Holdings, Inc.
• 10.8 Intuitive Surgical, Inc.
• 10.9 Abbott Laboratories
• 10.10 B. Braun Melsungen AG
• 10.11 ConMed Corporation
• 10.12 Karl Storz SE & Co. KG
• 10.13 Cook Medical
• 10.14 Applied Medical Resources Corporation
• 10.15 Richard Wolf GmbH
• 10.16 FUJIFILM Holdings Corporation
• 10.17 HOYA Corporation
• 10.18 Teleflex Incorporated
• 10.19 Arthrex, Inc.
• 10.20 NuVasive, Inc.